Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a lymphoproliferative disease (a type of condition affecting the cells of the immune system, such as lymphoma or leukaemia)
- People who are 18 years of age or older
- People who have received chemotherapy, biological treatment, or a combination of both as treatment for their lymphoproliferative disease
- People whose specialist doctor (a haemato-oncologist) has confirmed they are in remission, and that remission began less than one year ago (ongoing maintenance therapy is allowed)
- People who are able to complete questionnaires
- People who have signed a consent form agreeing to take part in the trial
Who may not be able to join:
- No exclusion criteria have been listed for this trial (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ilana Levy Yurkovski, MD, Bnai Zion Medical Center
Phone: 972-543295952
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Quality-of-life by EQ-5D scale
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.